The global Bruton’s Tyrosine Kinase (BTK) Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Bruton’s Tyrosine Kinase (BTK) Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Bruton’s Tyrosine Kinase (BTK) Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor include AbbVie, Johnson & Johnson, Principia Biopharma, Merck, Sunesis Pharmaceuticals, BeiGene, Novartis, Sanofi and Celgene Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bruton’s Tyrosine Kinase (BTK) Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bruton’s Tyrosine Kinase (BTK) Inhibitor.

Report Scope

The Bruton’s Tyrosine Kinase (BTK) Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bruton’s Tyrosine Kinase (BTK) Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bruton’s Tyrosine Kinase (BTK) Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Report

Report Metric	Details
Report Name	Bruton’s Tyrosine Kinase (BTK) Inhibitor Market
Segment by Type	Acalabrutinib Zanubrutinib Ibrutinib
Segment by Application	Tumor Autoimmunity
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AbbVie, Johnson & Johnson, Principia Biopharma, Merck, Sunesis Pharmaceuticals, BeiGene, Novartis, Sanofi, Celgene Corporation, Loxo, ArQule, Hengrui
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bruton’s Tyrosine Kinase (BTK) Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bruton’s Tyrosine Kinase (BTK) Inhibitor Market report?

Ans: The main players in the Bruton’s Tyrosine Kinase (BTK) Inhibitor Market are AbbVie, Johnson & Johnson, Principia Biopharma, Merck, Sunesis Pharmaceuticals, BeiGene, Novartis, Sanofi, Celgene Corporation, Loxo, ArQule, Hengrui

What are the Application segmentation covered in the Bruton’s Tyrosine Kinase (BTK) Inhibitor Market report?

Ans: The Applications covered in the Bruton’s Tyrosine Kinase (BTK) Inhibitor Market report are Tumor, Autoimmunity

What are the Type segmentation covered in the Bruton’s Tyrosine Kinase (BTK) Inhibitor Market report?

Ans: The Types covered in the Bruton’s Tyrosine Kinase (BTK) Inhibitor Market report are Acalabrutinib, Zanubrutinib, Ibrutinib

1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Overview

1.1 Product Overview and Scope of Bruton’s Tyrosine Kinase (BTK) Inhibitor

1.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Segment by Type

1.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2024-2030)

1.2.2 Acalabrutinib

1.2.3 Zanubrutinib

1.2.4 Ibrutinib

1.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Segment by Application

1.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value by Application: (2024-2030)

1.3.2 Tumor

1.3.3 Autoimmunity

1.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Estimates and Forecasts

1.4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2019-2030

1.4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2019-2030

1.4.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competition by Manufacturers

2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturers (2019-2024)

2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price by Manufacturers (2019-2024)

2.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Product Type & Application

2.7 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competitive Situation and Trends

2.7.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Bruton’s Tyrosine Kinase (BTK) Inhibitor Players Market Share by Revenue

2.7.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Retrospective Market Scenario by Region

3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region: 2019-2030

3.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region: 2019-2024

3.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region: 2025-2030

3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2019-2030

3.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2019-2024

3.3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2025-2030

3.4 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country

3.4.1 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2030)

3.4.3 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country

3.5.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2030)

3.5.3 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country

3.6.1 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2030)

3.6.3 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country

3.7.1 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2030)

3.7.3 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country

3.8.1 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2030)

3.8.3 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2019-2030)

4.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2019-2024)

4.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2025-2030)

4.1.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2019-2030)

4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2019-2030)

4.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2019-2024)

4.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2025-2030)

4.2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2019-2030)

4.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2019-2030)

5 Segment by Application

5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2019-2030)

5.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2019-2024)

5.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2025-2030)

5.1.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2019-2030)

5.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2019-2030)

5.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2019-2024)

5.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2025-2030)

5.2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2019-2030)

5.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AbbVie

6.1.1 AbbVie Corporation Information

6.1.2 AbbVie Description and Business Overview

6.1.3 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.1.5 AbbVie Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Principia Biopharma

6.3.1 Principia Biopharma Corporation Information

6.3.2 Principia Biopharma Description and Business Overview

6.3.3 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.3.5 Principia Biopharma Recent Developments/Updates

6.4 Merck

6.4.1 Merck Corporation Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Sunesis Pharmaceuticals

6.5.1 Sunesis Pharmaceuticals Corporation Information

6.5.2 Sunesis Pharmaceuticals Description and Business Overview

6.5.3 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.5.5 Sunesis Pharmaceuticals Recent Developments/Updates

6.6 BeiGene

6.6.1 BeiGene Corporation Information

6.6.2 BeiGene Description and Business Overview

6.6.3 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.6.4 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.6.5 BeiGene Recent Developments/Updates

6.7 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.7.5 Novartis Recent Developments/Updates

6.8 Sanofi

6.8.1 Sanofi Corporation Information

6.8.2 Sanofi Description and Business Overview

6.8.3 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.8.5 Sanofi Recent Developments/Updates

6.9 Celgene Corporation

6.9.1 Celgene Corporation Corporation Information

6.9.2 Celgene Corporation Description and Business Overview

6.9.3 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.9.5 Celgene Corporation Recent Developments/Updates

6.10 Loxo

6.10.1 Loxo Corporation Information

6.10.2 Loxo Description and Business Overview

6.10.3 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.10.5 Loxo Recent Developments/Updates

6.11 ArQule

6.11.1 ArQule Corporation Information

6.11.2 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Description and Business Overview

6.11.3 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.11.4 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.11.5 ArQule Recent Developments/Updates

6.12 Hengrui

6.12.1 Hengrui Corporation Information

6.12.2 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Description and Business Overview

6.12.3 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio

6.12.5 Hengrui Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Chain Analysis

7.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Mode & Process

7.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales and Marketing

7.4.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Channels

7.4.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors

7.5 Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers

8 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Dynamics

8.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Trends

8.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers

8.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges

8.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sunesis Pharmaceuticals

List of Tables

Table 1. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competitive Situation by Manufacturers in 2023

Table 4. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Product Type & Application

Table 12. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bruton’s Tyrosine Kinase (BTK) Inhibitor as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2019-2024) & (K Units)

Table 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2019-2024)

Table 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2025-2030) & (K Units)

Table 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2025-2030)

Table 21. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2019-2024)

Table 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2025-2030)

Table 25. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)

Table 27. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)

Table 28. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)

Table 32. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)

Table 33. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2019-2024)

Table 51. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2025-2030)

Table 52. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2019-2024)

Table 53. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2025-2030)

Table 54. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2019-2024)

Table 57. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2025-2030)

Table 58. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2019-2024)

Table 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2025-2030)

Table 60. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2019-2024)

Table 61. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2025-2030)

Table 62. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2019-2024)

Table 63. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2025-2030)

Table 64. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2019-2024)

Table 67. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2025-2030)

Table 68. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2019-2024)

Table 69. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2025-2030)

Table 70. AbbVie Corporation Information

Table 71. AbbVie Description and Business Overview

Table 72. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 74. AbbVie Recent Developments/Updates

Table 75. Johnson & Johnson Corporation Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Principia Biopharma Corporation Information

Table 81. Principia Biopharma Description and Business Overview

Table 82. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 84. Principia Biopharma Recent Developments/Updates

Table 85. Merck Corporation Information

Table 86. Merck Description and Business Overview

Table 87. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 89. Merck Recent Developments/Updates

Table 90. Sunesis Pharmaceuticals Corporation Information

Table 91. Sunesis Pharmaceuticals Description and Business Overview

Table 92. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 94. Sunesis Pharmaceuticals Recent Developments/Updates

Table 95. BeiGene Corporation Information

Table 96. BeiGene Description and Business Overview

Table 97. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 99. BeiGene Recent Developments/Updates

Table 100. Novartis Corporation Information

Table 101. Novartis Description and Business Overview

Table 102. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 104. Novartis Recent Developments/Updates

Table 105. Sanofi Corporation Information

Table 106. Sanofi Description and Business Overview

Table 107. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 109. Sanofi Recent Developments/Updates

Table 110. Celgene Corporation Corporation Information

Table 111. Celgene Corporation Description and Business Overview

Table 112. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 114. Celgene Corporation Recent Developments/Updates

Table 115. Loxo Corporation Information

Table 116. Loxo Description and Business Overview

Table 117. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 119. Loxo Recent Developments/Updates

Table 120. ArQule Corporation Information

Table 121. ArQule Description and Business Overview

Table 122. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 124. ArQule Recent Developments/Updates

Table 125. Hengrui Corporation Information

Table 126. Hengrui Description and Business Overview

Table 127. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product

Table 129. Hengrui Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors List

Table 133. Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers List

Table 134. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Trends

Table 135. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers

Table 136. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges

Table 137. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Bruton’s Tyrosine Kinase (BTK) Inhibitor

Figure 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Type in 2023 & 2030

Figure 4. Acalabrutinib Product Picture

Figure 5. Zanubrutinib Product Picture

Figure 6. Ibrutinib Product Picture

Figure 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Application in 2023 & 2030

Figure 9. Tumor

Figure 10. Autoimmunity

Figure 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size (2019-2030) & (US$ Million)

Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (2019-2030) & (K Units)

Figure 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price (US$/Unit) & (2019-2030)

Figure 15. Bruton’s Tyrosine Kinase (BTK) Inhibitor Report Years Considered

Figure 16. Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Manufacturers in 2023

Figure 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Bruton’s Tyrosine Kinase (BTK) Inhibitor Players: Market Share by Revenue in 2023

Figure 19. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)

Figure 22. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)

Figure 26. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)

Figure 27. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2019-2030)

Figure 34. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)

Figure 45. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Type (2019-2030)

Figure 55. Global Revenue Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Type (2019-2030)

Figure 56. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Application (2019-2030)

Figure 58. Global Revenue Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Application (2019-2030)

Figure 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2019-2030)

Figure 60. Bruton’s Tyrosine Kinase (BTK) Inhibitor Value Chain

Figure 61. Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions